You are here: Industry Insights > teva

News List

Just Biotherapeutics and Teva Form Biologics Partnership contractpharma
July 04, 2019
Will collaborate on the design and development of a high productivity biomanufacturing process.
Teva Launches 1% Sodium Hyaluronate in US americanpharmaceuticalreview
July 03, 2019
Teva has announced the launch of 1% Sodium Hyaluronate. The product received approval from the Center for Devices and Radiological Health of the U.S. Food and Drug Administration (FDA).
Just Biotherapeutics, Teva Enter Agreement for Design, Development of HP Biomanufacturing Process americanpharmaceuticalreview
July 01, 2019
Just Biotherapeutics announced they have entered into an agreement with Teva for the design and development of a high productivity (HP) biomanufacturing process.
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc. drugs
June 12, 2019
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc.
$85 million settlement agreed for opioid case in Oklahoma europeanpharmaceuticalreview
May 30, 2019
Teva has agreed to pay Oklahoma, resolving allegations that illegal marketing of its medication contributed to the state’s opioid epidemic.
Teva agrees to $85m settlement in Oklahoma opioid case pharmaceutical-technology
May 29, 2019
Teva Pharmaceutical has agreed to pay $85m to Oklahoma, resolving allegations that illegal marketing of the company’s pain medication contributed to the US state’s opioid epidemic.
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say nytimes
May 13, 2019
Leading drug companies including Teva, Pfizer, Novartis and Mylan conspired to inflate the prices of generic drugs by as much as 1,000 percent, according to a far-reaching lawsuit filed on Friday by 44 states.
Teva, amid massive restructuring, closes in on $3B cost-cutting goal fiercepharma
May 06, 2019
When Kåre Schultz joined Teva as CEO back in November 2017, the drugmaker was in a world of hurt. It was saddled with debt, costs were high and sales were falling.
Teva abandons Ajovy trial for cluster headaches pharmatimes
April 24, 2019
Teva has announced an update on its Ajovy (fremanezumab) clinical development for use in episodic cluster headache, after a Phase III study found that the primary endpoint for weekly average number of cluster headache attacks during the four-week treatmen
Teva launches generic version of VESIcare (solifenacin succinate) tablets in US pharmaceutical-business-review
April 24, 2019
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of VESIcare (solifenacin succinate) Tablets, 5 mg and 10 mg, in the U.S.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page